Actualité
Autre actualité
Diaclone ELISpot assays, tried and trusted by researchers worldwide
Date de publication : 01/04/2021
Plus d'info
Diaclone ELISpots (Enzyme-Linked Immunospot Assays) are highly specific immunoassays for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell...Rejoignez notre équipe !
Date de publication : 11/03/2021Dans le cadre du développement de sa nouvelle unité de production de plasmides GMP, RD-Biotech recrute deux nouveaux profils :
Plus d'info
- Technicien(ne) Bioproduction Biologie...DIACLONE ELISpot Kits - A new format to meet your demands
Date de publication : 25/02/2021The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT Plus d'infoRD-Biotech lauréate de l’appel à projet France Relance !
Date de publication : 15/02/2021
Plus d'info
RD-Biotech lauréate de l’appel à projet France Relance !
RD-BIOTECH, voit son projet de construction d’une unité de production...Fière d’avoir participé au développement du vaccin contre la COVID-19
Date de publication : 21/01/2021Toute l’équipe de RD-Biotech est fière d’avoir participé au développement du vaccin contre la COVID-19 et remercie BioNTech pour sa confiance...
Plus d'infoNew at Diaclone - SARS-CoV-2 ELISA set
Date de publication : 24/11/2020Diaclone continues to innovate and provide you with new research tools.
Plus d'info
Build your own serological assay with our new SARS-CoV-2 ELISA set.
Contact Diaclone for more information...NEW AT DIACLONE!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS
Date de publication : 15/10/2020Developed in our laboratories in France Plus d'infoAnti-S1 Domain Spike Protein is now available at Diaclone
Date de publication : 03/08/2020
Plus d'info
Ideal for your COVID-19 studies...
The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19)...IL1RAP, a therapeutic target for oncologic treatment
Date de publication : 31/07/2020IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams have been able...
Plus d'infoDo you know the real potential of AAV?
Date de publication : 01/07/2020Revealing the full potential of Adeno Associated Virus thanks to molecular biology
Plus d'info
Adeno-associated virus (AAV) is a small and single-strand DNA virus. In 1960, this non-enveloped entity was...What you need to know about Exosomes
Date de publication : 01/07/2020“Huge opportunities”. “Many hurdles”. “Enormous potential”...
Plus d'info
It's just an excerpt of the several terms you'll come across if you search for them on the...Complete Proteome of COVID-19
Date de publication : 15/06/2020Are you familiar with all the proteins of SARS-CoV-2?
Plus d'info
Read more on Linked In
Are you working on any of these proteins?
Which one would you like to see developed and validated?
Contact...RD-Biotech fournisseur des anticorps monoclonaux murins D1-25 et 1112-1, pour la quantification par ELISA de la glycoprotéine G du virus de la rage
Date de publication : 15/06/2020Signature d’accord de licence avec Institut Pasteur (France) et le Winstar Institute (USA) permettant à RD-Biotech de commercialiser les 2 anticorps monoclonaux murins D1-25 et 1112-1...
Plus d'infoPatients’ Immune Battle Against COVID-19
Date de publication : 27/05/2020A brief review of the expected complications of CovId-19 infection.
Plus d'info
Read more on Linked In
Diaclone offers a specific range of Antibodies, ELISA and ELISpot kits for COVID-19 research that can...Fast track your Covid-19 Research with Diaclone’s CYTOKINES
Date de publication : 26/05/2020Diaclone manufactures essential tools for Cytokine Storm monitoring & Immunotherapy...
Plus d'infoRD-BIOTECH produit les anticorps monoclonaux pour le test de dépistage de COVID-19 « Ag Respi-Strip » développé par CorisBioConcept !
Date de publication : 03/04/2020RD-BIOTECH, acteur majeur en France dans la production d’anticorps monoclonaux et de protéines recombinantes est partenaire de la société belge Coris...
Plus d'infoThe Future of Therapeutic Antibody Development
Date de publication : 12/03/2020The mAbexperts team has developed strong expertise in molecular biology to help you generate new formats of monoclonal antibodies.
Plus d'info
Read more on LinkedIn
mAbexperts is a group...Antibody Humanization
Date de publication : 05/03/2020Many articles about antibodies refer to the term “humanization”.
Plus d'info
But what does humanization mean? What technical approaches are used to carry out such a process? What are the...Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon
Date de publication : 21/08/2018Le Projet MiMédi
Plus d'info
MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"
Au sein...